Hairy Heel Wart Vaccine

Novartis Animal Vaccines, Inc., introduces Trep ShieldTM HW Treponema Bacterin, the first vaccine for hairy heel warts to receive full license approval from the United States Department of Agriculture (USDA). Trep Shield is proven to reduce new cases of digital dermatitis (hairy heel warts or foot warts) by protecting dairy cows and heifers from Treponema spp., the spiral-shaped bacteria that are a major cause of these painful foot lesions. USDA estimates that hairy heel warts affect at least 80 percent of U.S. dairy herds having more than 200 cows. Trep Shield efficacy was proven in a field trial with 500 cows and heifers on a commercial dairy operation with a high exposure to the disease. Four weeks after vaccination with Trep Shield, the incidence of new heel wart cases in heifers was reduced by 45 percent and in cows by 27 percent, compared to controls. To establish immunity, producers should administer three shots of Trep Shield, each 21 days apart. Booster as recommended by your veterinarian to maintain protection.Novartis says that controlling heel warts can help dairy producers maintain herd production, longevity and reproductive performance. Research shows that each case of heel warts costs $150 or more due to lower milk production, extra days open, increased culling and treatment expense.By preventing hairy heel warts with Trep Shield, producers also may be able to reduce the frequency of footbaths, with their associated environmental concerns, expense and disposal problems.

For fastest response call (913) 451-2708 or visit the Web site at www.TrepShield.com.